PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+46.43%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$153M
AUM Growth
+$153M
(+40%)
Cap. Flow
+$4.01M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
41.14%
Holding
109
New
16
Increased
26
Reduced
37
Closed
9
Top Buys
| 1 |
Cantaloupe
CTLP
|
$2.67M |
| 2 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$2.2M |
| 3 |
Elutia
ELUT
|
$1.9M |
| 4 |
SHSP
SharpSpring, Inc.
SHSP
|
$1.72M |
| 5 |
INTZ
INTRUSION INC NEW
INTZ
|
$1.07M |
Top Sells
| 1 |
Magnite
MGNI
|
$2.63M |
| 2 |
BioLife Solutions
BLFS
|
$1.06M |
| 3 |
QUMU
Qumu Corp.
QUMU
|
$1M |
| 4 |
Digital Turbine
APPS
|
$989K |
| 5 |
NeoGenomics
NEO
|
$984K |
Sector Composition
| 1 | Healthcare | 64.3% |
| 2 | Technology | 12.83% |
| 3 | Communication Services | 8.46% |
| 4 | Industrials | 4.04% |
| 5 | Consumer Staples | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $9.76M | 6.38% | 181,250 -18,275 | -9% | -$984K |
|
2
Vericel Corp
VCEL
$1.83B
| $7.81M | 5.11% | 253,037 -23,860 | -9% | -$737K |
|
3
CareDx
CDNA
$727M
| $7.81M | 5.11% | 107,792 -11,800 | -10% | -$855K |
|
4
Natera
NTRA
$23.1B
| $6.57M | 4.3% | 66,050 -4,650 | -7% | -$463K |
|
5
Veracyte
VCYT
$2.39B
| $6.22M | 4.07% | 127,080 -3,500 | -3% | -$171K |
|
|
6
Magnite
MGNI
$3.7B
| $5.88M | 3.85% | 191,500 -85,500 | -31% | -$2.63M |
|
7
Idexx Laboratories
IDXX
$51.8B
| $5.55M | 3.63% | 11,105 -100 | -0.9% | -$50K |
|
8
Axogen
AXGN
$743M
| $4.97M | 3.25% | 277,490 -8,700 | -3% | -$156K |
|
9
OptimizeRx
OPRX
$335M
| $4.88M | 3.19% | 156,688 -12,072 | -7% | -$376K |
|
10
Microsoft
MSFT
$3.77T
| $3.45M | 2.25% | 15,493 -500 | -3% | -$111K |
|
11
FlexShopper
FPAY
$17M
| $3.36M | 2.19% | 1,305,530 +88,400 | +7% | +$227K |
|
12
Abbott
ABT
$231B
| $3.02M | 1.98% | 27,580 -450 | -2% | -$49.3K |
|
13
Alphatec Holdings
ATEC
$2.35B
| $2.67M | 1.74% | 183,750 -2,500 | -1% | -$36.3K |
|
|
14
Cantaloupe
CTLP
$797M
| $2.67M | 1.74% | +254,325 | New | +$2.67M |
|
|
AKTS
15
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $2.5M | 1.63% | 204,200 +8,900 | +5% | +$109K |
|
16
Rockwell Medical
RMTI
$58.9M
| $2.48M | 1.62% | 2,457,425 +613,200 | +33% | +$619K |
|
17
Inuvo
INUV
$49.5M
| $2.47M | 1.62% | 5,457,836 +817,625 | +18% | +$370K |
|
|
BEAT
18
DELISTED
BioTelemetry, Inc.
BEAT
| $2.35M | 1.53% | 32,535 -1,700 | -5% | -$123K |
|
19
Castle Biosciences
CSTL
$696M
| $2.32M | 1.52% | 34,500 -400 | -1% | -$26.9K |
|
20
Eli Lilly
LLY
$657B
| $2.31M | 1.51% | 13,708 -250 | -2% | -$42.2K |
|
21
AtriCure
ATRC
$1.84B
| $2.29M | 1.5% | 41,100 -3,250 | -7% | -$181K |
|
|
CSII
22
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.27M | 1.48% | 51,757 -2,693 | -5% | -$118K |
|
|
SOLO
23
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $2.21M | 1.45% | 357,500 | – | – |
|
24
LeMaitre Vascular
LMAT
$2.16B
| $2.21M | 1.45% | 54,600 -2,100 | -4% | -$85K |
|
25
Standard BioTools
LAB
$481M
| $2.21M | 1.45% | 368,400 +35,975 | +11% | +$216K |
|